Prognostic Value of Proadrenomedulin in Severe Sepsis and Septic Shock Is Independent of Etiology and Focus of Infection
| Autor: | S Gonzalez De Zarate, Dolores Calvo, C Andres, E Zarca, MF Muñoz, D Andaluz-Ojeda, J Bermejo, Ramón Cicuendez, Leonor Nogales, A Bueno, José María Eiros, F Gandia, P Bueno |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
business.industry Septic shock Prohormone Disease Plasma levels Critical Care and Intensive Care Medicine medicine.disease Gastroenterology Pneumonia Internal medicine Poster Presentation Etiology Medicine Prognostic biomarker business Intensive care medicine Severe sepsis medicine.drug |
| Zdroj: | Intensive Care Medicine Experimental |
| ISSN: | 2197-425X |
| Popis: | Proadrenomedulin (proADM) is a novel prognostic biomarker employed in pneumonia and more recently in severe sepsis and septic shock. Release kinetics of proADM in this disease has not been studied. in this research we analyze the variation in plasma levels of this prohormone based upon the type of causative agent, the site of infection and the presence of renal failure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink